Tryptase-Positive Mast Cells Correlate with Angiogenesis in Canine Mammary Carcinoma

Journal of Comparative Pathology

Volumn 144, Issue 2-3, 2011, Pages 157-163

  Im, K S ^a   Kim, J H ^a   Yhee, J Y ^a   Yu, C H ^a   Kim, N H ^a   Nho, W G ^b   Sur, J H ^a  

^a Konkuk University   (South Korea)

^b National Institute of Animal Science   (South Korea)

Author keywords

Angiogenesis; Canine mammary carcinomas; Mast cell; Mast cell tryptase

Indexed keywords

ANGIOGENIC FACTOR; TRYPTASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CANCER TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOG; ENDOTHELIUM; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MAST CELL; METASTASIS; MICROENVIRONMENT; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; STAINING; TUMOR GROWTH;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CASE-CONTROL STUDIES; COLORING AGENTS; DOG DISEASES; DOGS; FEMALE; MAMMARY NEOPLASMS, ANIMAL; MAST CELLS; MICROVESSELS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; STAINING AND LABELING; TOLONIUM CHLORIDE; TRYPTASES; TUMOR MICROENVIRONMENT;

EID: 79551481504     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2010.08.006     Document Type: Article

References (34)

1. Ackermann M.R. Acute inflammation. Pathologic Basis of Veterinary Disease 2007, 117-118. Mosby Elsevier, Philadelphia. M.D. McGavin, J.F. Zachary (Eds.).
2. Ackermann M.R. Chronic inflammation and wound healing. Pathologic Basis of Veterinary Disease 2007, Mosby Elsevier, Philadelphia, p. 174. M.D. McGavin, J.F. Zachary (Eds.).
3. Benitez-Bribiesca L., Wong A., Utrera D., Castellanos E. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. Journal of Histochemistry and Cytochemistry 2001, 49:1061-1062.
4. Billen F., Peeters D., Dehard S., Day M.J., Clercx C. Distribution of leucocyte subsets in the canine pharyngeal tonsil. Journal of Comparative Pathology 2006, 135:63-73.
5. Blair R.J., Meng H., Marchese M.J., Ren S., Schwartz L.B., et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. Journal of Clinical Investigation 1997, 99:2691-2700.
6. Dabiri S., Huntsman D., Makretsov N., Cheang M., Gilks B., et al. The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis. Modern Pathology 2004, 17:690-695.
7. Elpek G.O., Gelen T., Aksoy N.H., Erdogan A., Dertsiz L., et al. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. Journal of Clinical Pathology 2001, 54:940-944.
8. Graham J.C., Myers R.K. The prognostic significance of angiogenesis in canine mammary tumors. Journal of Veterinary Internal Medicine 1999, 13:416-418.
9. Grutzkau A., Kruger-Krasagakes S., Baumeister H., Schwarz C., Kogel H., et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Molecular Biology of the Cell 1998, 9:875-884.
10. Kankkunen J.P., Harvima I.T., Naukkarinen A. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. International Journal of Cancer 1997, 72:385-388.
11. Kashiwase Y., Morioka J., Inamura H., Yoshizawa Y., Usui R., et al. Quantitative analysis of mast cells in benign and malignant breast lesions. Immunohistochemical study on formalin-fixed, paraffin-embedded tissues. International Archives of Allergy and Immunology 2004, 134:199-205.
12. Kerbel R., Folkman J. Clinical translation of angiogenesis inhibitors. Nature Reviews Cancer 2002, 2:727-739.
13. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
14. Misdorp W. Tumors of the mammary gland. Tumors in Domestic Animals 2002, 586-588. Blackwell, Iowa. D.J. Meuten (Ed.).
15. Misdorp W., Else R.W., Hellmen E., Lipscomb T.P. Histological Classification of Mammary Tumors of the Dog and the Cat 1999, Armed Forces Institute of Pathology, American Registry of Pathology and World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology, Washington, DC, pp. 11-56.
16. Morrison W.B. Canine and feline mammary tumors. Cancer in Dogs and Cats Medical and Surgical Management 2002, Tenton NewMedia, Jackson, p. 565. C.C. Cann (Ed.).
17. Nienartowicz A., Sobaniec-Lotowska M.E., Jarocka-Cyrta E., Lemancewicz D. Mast cells in neoangiogenesis. Medical Science Monitor 2006, 12:RA53-RA56.
18. Norrby K. Mast cells and angiogenesis. Acta Pathologica, Microbiologica et Immunologica Scandinavica 2002, 110:355-371.
19. Peeters D., Day M.J., Farnir F., Moore P., Clercx C. Distribution of leucocyte subsets in the canine respiratory tract. Journal of Comparative Pathology 2005, 132:261-272.
20. Raber T.L., Buckner L. Cytopathology techniques. Advanced Laboratory Methods in Histology and Pathology 1994, Armed Forces Institute of Pathology and American Registry of Pathology, Washington, DC, p. 113. U.V. Mikel (Ed.).
21. Restucci B., De Vico G., Maiolino P. Evaluation of angiogenesis in canine mammary tumors by quantitative platelet endothelial cell adhesion molecule immunohistochemistry. Veterinary Pathology 2000, 37:297-301.
22. Ribatti D., Crivellato E., Roccaro A.M., Ria R., Vacca A. Mast cell contribution to angiogenesis related to tumour progression. Clinical and Experimental Allergy 2004, 34:1660-1664.
23. Ribatti D., Ennas M.G., Vacca A., Ferreli F., Nico B., et al. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. European Journal of Clinical Investigation 2003, 33:420-425.
24. Ribatti D., Finato N., Crivellato E., Marzullo A., Mangieri D., et al. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. American Journal of Obstetrics and Gynecology 2005, 193:1961-1965.
25. Ribatti D., Vacca A., Marzullo A., Nico B., Ria R., et al. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. International Journal of Cancer 2000, 85:171-175.
26. Ribatti D., Vacca A., Nico B., Quondamatteo F., Ria R., et al. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. British Journal of Cancer 1999, 79:451-455.
27. Ruegg C., Hasmim M., Lejeune F.J., Alghisi G.C. Antiangiogenic peptides and proteins: from experimental tools to clinical drugs. Biochimica et Biophysica Acta 2006, 1765:155-177.
28. Sawatsubashi M., Yamada T., Fukushima N., Mizokami H., Tokunaga O., et al. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Archiv 2000, 436:243-248.
29. Soucek L., Lawlor E.R., Soto D., Shchors K., Swigart L.B., et al. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nature Medicine 2007, 13:1211-1218.
30. Takanami I., Takeuchi K., Naruke M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 2000, 88:2686-2692.
31. Tan S.T., Wallis R.A., He Y., Davis P.F. Mast cells and hemangioma. Plastic and Reconstructive Surgery 2004, 113:999-1011.
32. Tashbaeva R.E., Hwang D.N., Song G.S., Choi N.H., Lee J.H., et al. Cellular characterization of multidrug resistance P-glycoprotein, alpha fetoprotein, and neovascular endothelium-associated antigens in canine hepatocellular carcinoma and cirrhotic liver. Veterinary Pathology 2007, 44:600-606.
33. Vicari A.P., Caux C. Chemokines in cancer. Cytokine and Growth Factor Reviews 2002, 13:143-154.
34. Wedemeyer J., Galli S.J. Decreased susceptibility of mast cell-deficient Kit(W)/Kit(W-v) mice to the development of 1, 2-dimethylhydrazine-induced intestinal tumors. Laboratory Investigation 2005, 85:388-396.